Is Hepatocyte Necrosis a Good Marker of Donor Liver Viability During Machine Perfusion?
Hepatol Commun
.
2022 Feb;6(2):435-436.
doi: 10.1002/hep4.1816.
Epub 2021 Sep 2.
Authors
Desley A H Neil
1
2
,
Hynek Mergental
2
3
4
,
Angus Hann
2
3
,
Richard W Laing
2
3
,
Hermien Hartog
3
,
Darius F Mirza
2
3
4
,
M Thamara P R Perera
3
Affiliations
1
Department of Cellular Pathology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
2
Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
3
Liver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
4
National Institute for Health Research, Birmingham Biomedical Research Centre, University of Birmingham and UHBFT, Birmingham, United Kingdom.
PMID:
34558864
PMCID:
PMC8793988
DOI:
10.1002/hep4.1816
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Hepatocytes
Humans
Liver
Liver Transplantation*
Living Donors
Necrosis
Perfusion
Grants and funding
WT_/Wellcome Trust/United Kingdom
200121/B/15/Z/WT_/Wellcome Trust/United Kingdom